Hospital care: improving outcomes in type 1 diabetes.
Journal
Current opinion in endocrinology, diabetes, and obesity
ISSN: 1752-2978
Titre abrégé: Curr Opin Endocrinol Diabetes Obes
Pays: England
ID NLM: 101308636
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
pubmed:
15
12
2020
medline:
7
1
2021
entrez:
14
12
2020
Statut:
ppublish
Résumé
Caring for patients with type 1 diabetes (T1D) in the hospital presents unique challenges. This review provides an update on significant issues relevant to the inpatient management of T1D. Topics include trends in diabetic ketoacidosis (DKA), hypoglycemia, and adapting ambulatory technologies for inpatient use. Rates of DKA in the United States are rising. Although socioeconomic status, health insurance coverage, and hemoglobin A1c are persistently associated with DKA in individuals with T1D, newer risk factors have also emerged. These include the off-label use of sodium-glucose cotransporter inhibitor medications, immune checkpoint inhibitor-induced diabetes, and infection with severe acute respiratory syndrome coronavirus 2. Hypoglycemia is common among hospitalized patients with T1D. Use of validated hypoglycemia risk prediction models and multidisciplinary care initiatives can reduce the risk of inpatient hypoglycemia. Finally, continuous glucose monitoring is being adapted for use in the hospital setting and has shown promise during the coronavirus disease 2019 (COVID-19) pandemic. Evidence-based treatment algorithms, risk prediction calculators, multidisciplinary interventions, and wearable technology hold promise for improved outcomes in hospitalized patients with T1D.
Identifiants
pubmed: 33315629
pii: 01266029-202102000-00004
doi: 10.1097/MED.0000000000000601
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
14-20Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Références
Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2020.
Rogers MA, Kim C, Banerjee T, Lee JM. Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study. BMC Med 2017; 15:1–9. [cited 2020 Oct 25].
Mendez CE, Umpierrez GE. Management of type 1 diabetes in the hospital setting. Curr Diabetes Rep 2017; 17:98.
Maahs DM, Hermann JM, Holman N, et al. Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Diabetes Care 2015; 38:1876–1882.
Fazeli Farsani S, Brodovicz K, Soleymanlou N. Correction: Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. BMJ Open 2017; 7:e016587DOI:10.1136/bmjopen-2017-016587corr1.
doi: 10.1136/bmjopen-2017-016587corr1
Realsen J, Goettle H, Chase HP. Morbidity and mortality of diabetic ketoacidosis with and without insulin pump care. Diabetes Technol Ther 2012; 14:1149–1154.
Brandstaetter E, Bartal C, Sagy I, et al. Recurrent diabetic ketoacidosis. Arch Endocrinol Metab 2019; 63:153–535.
Benoit SR, Hora I, Pasquel FJ, et al. Trends in emergency department visits and inpatient admissions for hyperglycemic crises in adults with diabetes, United States, 2006–2015. Diabetes Care 2020; 43:1057–1064.
Ramphul K, Joynauth J. An update on the incidence and burden of diabetic ketoacidosis in the U.S. Diabetes Care 2020; 43:e196–e197.
Todd Alonso G, Coakley A, Pyle L, et al. Diabetic ketoacidosis at diagnosis of type 1 diabetes in Colorado children, 2010–2017. Diabetes Care 2020; 43:117–121.
Dhatariya KK. Defining and characterising diabetic ketoacidosis in adults. Diabetes Res Clin Pract 2019; 155:107797.
Vakharia JD, Agrawal S, Molino J, Topor LS. Family history of diabetes is associated with increased risk of recurrent diabetic ketoacidosis in pediatric patients. Endocr Pract 2020; 26:305–311.
Semenkovich K, Berlin KS, Ankney RL, et al. Predictors of diabetic ketoacidosis hospitalizations and hemoglobin A1c among youth with type 1 diabetes. Heal Psychol 2019; 38:577–585.
Wolf RA, Haw JS, Paul S, et al. Hospital admissions for hyperglycemic emergencies in young adults at an inner-city hospital. Diabetes Res Clin Pract 2019; 157:107869.
Everett E, Mathioudakis NN. Association of socioeconomic status and DKA readmission in adults with type 1 diabetes: Analysis of the US National Readmission Database. BMJ Open Diabetes Res Care 2019; 7:e000621.
Boeder S, Edelman SV. Sodium-glucose co-transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: a review of randomized controlled trials. Diabetes, Obesity and Metabolism 2019; 21: (Suppl. 2): 62–77.
Danne T, Garg S, Peters AL, et al. International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors. Diabetes Care 2019; 42:1147–1154.
Hampp C, Swain RS, Horgan C, et al. Use of sodium-glucose cotransporter 2 inhibitors in patients with type 1 diabetes and rates of diabetic ketoacidosis. Diabetes Care 2020; 43:90–97.
Tsang VH, Mcgrath RT, Clifton-Bligh RJ, et al. Checkpoint inhibitor-associated autoimmune diabetes is distinct from type 1 diabetes. J Clin Endocrinol Metab 2019; 104:5499–5506.
De Filette JM, Pen JJ, Decoster L, et al. Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review [Internet]. European Journal of Endocrinology 2019; 181:363–374.
Chow N, Fleming-Dutra K, Gierke R, et al. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:382–386.
Ebekozien OA, Noor N, Gallagher MP, Alonso GT. Type 1 diabetes and covid-19: preliminary findings from a multicenter surveillance study in the U.S. Diabetes Care 2020; 43:e83–e85.
Galm BP, Bagshaw SM, Senior PA. Acute management of diabetic ketoacidosis in adults at 3 teaching hospitals in Canada: a multicentre, retrospective cohort study. Can J Diabetes 2019; 43:309–315.e2.
Baumer-Mouradian SH, Gray MP, Wolfgram PM, et al. Improving emergency department management of diabetic ketoacidosis in children. Pediatrics 2019; 144:e20182984.
Flood K, Nour M, Holt T, et al. Implementation and evaluation of a diabetic ketoacidosis order set in pediatric type 1 diabetes at a tertiary care hospital: a quality-improvement initiative. Can J Diabetes 2019; 43:297–303.
Mohamed M, Assal A, Boyle L, et al. Development and implementation of a diabetic ketoacidosis protocol for adults with type 1 and type 2 diabetes at a tertiary care multicampus hospital. Can J Diabetes 2019; 43:256–260.e3.
Balmier A, Dib F, Serret-Larmande A, et al. Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study. Ann Intensive Care 2019; 9:91.
Firestone RL, Parker PL, Pandya KA, et al. moderate-intensity insulin therapy is associated with reduced length of stay in critically ill patients with diabetic ketoacidosis and hyperosmolar hyperglycemic state. Crit Care Med 2019; 47:700–705.
Groysman AY, Peragallo-Dittko V, Islam S, Klek S. Safety and efficacy of glucostabilizer in the management of diabetic ketoacidosis. Endocr Pract 2020; 26:627–633.
Heller SR. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: A joint position statement of the American diabetes association and the European association for the study of diabetes. Diabetes Care 2017; 40:155–157.
Berra C, De Fazio F, Azzolini E, et al. Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population. Acta Diabetol 2019; 56:931–938.
Sinclair AJ, Dunning T, Dhatariya K, et al. Clinical guidelines for type 1 diabetes mellitus with an emphasis on older adults: an Executive Summary. Diabet Med 2020; 37:53–70.
Peled S, Pollack R, Elishoov O, et al. Association of inpatient glucose measurements with amputations in patients hospitalized with acute diabetic foot. J Clin Endocrinol Metab 2019; 104:5445–5452.
Nishioka Y, Okada S, Noda T, et al. Absolute risk of acute coronary syndrome after severe hypoglycemia: a population-based 2-year cohort study using the National Database in Japan. J Diabetes Investig 2020; 11:426–434.
Carvalho RC, Nishi FA, Ribeiro TB, et al. Association between intra-hospital uncontrolled glycemia and health outcomes in patients with diabetes: a systematic review of observational studies. Curr Diabetes Rev 2020; 16: doi: 10.2174/1573399816666200130093523. [Online ahead of print].
doi: 10.2174/1573399816666200130093523.
Lake A, Arthur A, Byrne C, et al. The effect of hypoglycaemia during hospital admission on health-related outcomes for people with diabetes: a systematic review and meta-analysis. Diabet Med 2019; 36:1349–1359.
Lee J, Kim TM, Kim H, et al. Differences in clinical outcomes between patients with and without hypoglycemia during hospitalization: a retrospective study using real-world evidence. Diabetes Metab J 2020; 44:555–565.
Cryer PE. Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin North Am 2010; 39:641–654.
Shah BR, Walji S, Kiss A, et al. Derivation and validation of a risk-prediction tool for hypoglycemia in hospitalized adults with diabetes: the hypoglycemia during hospitalization (HyDHo) score. Can J Diabetes 2019; 43:278–282.e1.
Mathioudakis NN, Everett E, Routh S, et al. Development and validation of a prediction model for insulin-associated hypoglycemia in noncritically ill hospitalized adults. BMJ Open Diabetes Res Care 2018; 6:e000499.
Ruan Y, Moysova Z, Tan GD, et al. Inpatient hypoglycaemia: understanding who is at risk. Diabetologia 2020; 63:1299–1304.
Ruan Y, Bellot A, Moysova Z, et al. Predicting the risk of inpatient hypoglycemia with machine learning using electronic health records. Diabetes Care 2020; 43:1504–1511.
Cruz P. Inpatient hypoglycemia: the challenge remains. J Diabetes Sci Technol 2020; 14:560–566.
Kravchenko MI, Tate JM, Clerc PG, et al. Impact of structured insulin order sets on inpatient hypoglycemia and glycemic control. Endocr Pract 2020; 26:523–528.
Kadayakkara DK, Balasubramanian P, Araque K, et al. Multidisciplinary strategies to treat severe hypoglycemia in hospitalized patients with diabetes mellitus reduce inpatient mortality rate: Experience from an academic community hospital. PLoS One 2019; 14:e0220956.
Shea KE, Gerard SO, Krinsley JS. Reducing hypoglycemia in critical care patients using a nurse-driven root cause analysis process. Crit Care Nurse 2019; 39:29–39.
Bain A, Hasan SS, Kavanagh S, Babar ZU. Research: care delivery strategies to reduce insulin prescribing errors in UK hospitals: results from a national survey. Diabet Med 2020; 37:1176–1184.
Avanzini F, Marelli G, Amodeo R, et al. The ‘brick diet’ and postprandial insulin: a practical method to balance carbohydrates ingested and prandial insulin to prevent hypoglycaemia in hospitalized persons with diabetes. Diabet Med 2020; 37:1125–1133.
Galindo RJ, Umpierrez GE, Rushakoff RJ, et al. Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline. J Diabetes Sci Technol 2020; 14:1035–1064.
AD Association. Diabetes technology: standards of medical care in diabetes – 2020. Diabetes Care 2020; 43: (Suppl. 1): S77–S88.
Wang M, Singh LG, Spanakis EK. Advancing the use of CGM devices in a non-ICU setting. J Diabetes Sci Technol 2019; 13:674–681.
Kotzapanagiotou E, Tsotridou E, Volakli E, et al. Evaluation of continuous flash glucose monitoring in a pediatric ICU setting. J Clin Monit Comput 2020; 34:843–852.
Moser O, Pandis M, Aberer F, et al. A head-to-head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: hypoglycaemia remains the weak spot. Diabetes, Obes Metab 2019; 21:1043–1048.
Nair BG, Dellinger EP, Flum DR, et al. A pilot study of the feasibility and accuracy of inpatient continuous glucose monitoring. Diabetes Care 2020; 43:dc200670.
Singh LG, Satyarengga M, Marcano I, et al. Reducing inpatient hypoglycemia in the general wards using real-time continuous glucose monitoring: the glucose telemetry system, a randomized clinical trial. Diabetes Care 2020; 43:2736–2743.
Fortmann AL, Spierling Bagsic SR, Talavera L, et al. Glucose as the fifth vital sign: a randomized controlled trial of continuous glucose monitoring in a non-ICU hospital setting. Diabetes Care 2020; 43:2873–2877.
Apicella M, Campopiano MC, Mantuano M, et al. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol 2020; 8:782–792.
Bode B, Garrett V, Messler J, et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol 2020; 14:813–821.
Al-Jaghbeer MJ, Lansang MC. Hyperglycemia management in the critically ill patient with COVID-19. Cleve Clin J Med 2020; doi: 10.3949/ccjm.87a.ccc012. [Online ahead of print].
doi: 10.3949/ccjm.87a.ccc012.
FDA. Coronavirus (COVID-19) Update: FDA allows expanded use of devices to monitor patients’ vital signs remotely. FDA [Internet]. 2020 [cited 2020 Oct 25]. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-allows-expanded-use-devices-monitor-patients-vital-signs-remotely .
Galindo RJ, Aleppo G, Klonoff DC, et al. Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic. J Diabetes Sci Technol 2020; 14:822–832.
Jankovic I, Basina M. Proposed use of continuous glucose monitoring for care of critically ill COVID-19 patients. J Diabetes Sci Technol 2020; 1932296820965203doi:10.1177/1932296820965203. [Online ahead of print].
doi: 10.1177/1932296820965203.
Reutrakul S, Genco M, Salinas H, et al. Feasibility of inpatient continuous glucose monitoring during the COVID-19 pandemic: early experience. Diabetes Care 2020; 43:e137–e138.
Sadhu AR, Serrano IA, Xu J, et al. Continuous glucose monitoring in critically ill patients with COVID-19: results of an emergent pilot study. J Diabetes Sci Technol 2020; 14:1065–1073.